Synagis

In the US, Synagis (palivizumab systemic) is a member of the drug class immune globulins and is used to treat Respiratory Syncytial Virus.

US matches:

UK matches:

Ingredient matches for Synagis

Palivizumab

Palivizumab is reported as an ingredient of Synagis in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • Colombia
  • Costa Rica
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • El Salvador
  • Finland
  • France
  • Germany
  • Greece
  • Guatemala
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Luxembourg
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Nicaragua
  • Norway
  • Oman
  • Panama
  • Peru
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)